Duane Mitchell

13PUBLICATIONS

57CO-AUTHORS

Molecular targetsGene and molecular therapyStylistics and textual analysisCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 24, 2026

Improving Immune Checkpoint Blockade Efficacy in Melanoma Brain Metastases through Myddosomal inhibition with Emavusertib.

|Jun 12, 2025

A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.

Eric M Thompson, David M Ashley, Katayoun Ayasoufi

|Aug 19, 2024

Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma.

Changlin Yang, Vrunda Trivedi, Kyle Dyson

|Jul 12, 2024

Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade.

Christina A von Roemeling, Jeet A Patel, Savannah L Carpenter

|Jan 24, 2024

mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors.

Vrunda Trivedi, Changlin Yang, Kelena Klippel

|Nov 28, 2023

CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade.

Christina von Roemeling, Oleg Yegorov, Changlin Yang

Pageof 3

Frequent Collaborators

3 joint publications

Bently P Doonan

3 joint publications

Christina A Von Roemeling

Adam J Grippin

Tyler J Wildes

Vrunda Trivedi

Ginger Moore

C Flores

J Drake

J Gil

J Dean

Frequent Collaborators

3 joint publications

Bently P Doonan

3 joint publications

Christina A Von Roemeling

3 joint publications

Adam J Grippin

2 joint publications

Tyler J Wildes